Slide 146 Interventions for Tuberculosis Control and Elimination
next Next
previous Previous
beginning First
last Last
The policy to use six months of isoniazid became widespread and the common standard among any patient. A study with a five-year follow-up in Uganda among patients with HIV infection showed, however, that the five-year benefit of six months isoniazid was nil in comparison with placebo.
Go to top

Last update: September 29, 2010